Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Predictors of pulmonary exacerbation treatment in cystic fibrosis.

Sanders DB, Ostrenga JS, Rosenfeld M, Fink AK, Schechter MS, Sawicki GS, Flume PA, Morgan WJ.

J Cyst Fibros. 2019 Jun 27. pii: S1569-1993(18)30763-X. doi: 10.1016/j.jcf.2019.06.008. [Epub ahead of print]

PMID:
31257102
2.

Readiness for transition and health-care satisfaction in adolescents with complex medical conditions.

Haarbauer-Krupa J, Alexander NM, Mee L, Johnson A, Wise J, Arora Gupta N, Schechter MS, Wasilewski-Masker K, Gilleland Marchak J.

Child Care Health Dev. 2019 May;45(3):463-471. doi: 10.1111/cch.12656.

PMID:
30836446
3.

Origins of growth deficiencies in cystic fibrosis.

Le TN, Schechter MS.

Thorax. 2019 May;74(5):423-424. doi: 10.1136/thoraxjnl-2019-213076. Epub 2019 Feb 23. No abstract available.

PMID:
30798253
4.

Identifying and Integrating Parent Priorities for Psychosocial Support Services in a Pediatric Cystic Fibrosis Clinic.

Everhart RS, Molitor SJ, Wentz D, Schmidt HJ, Schechter MS.

J Clin Psychol Med Settings. 2019 Jun;26(2):235-241. doi: 10.1007/s10880-018-9588-1.

PMID:
30368723
5.

Rate and predictors of prescription of lumacaftor - Ivacaftor in the 18 months following approval in the United States.

Sawicki GS, Fink AK, Schechter MS, Loeffler DR, Mayer-Hamblett N.

J Cyst Fibros. 2018 Nov;17(6):742-746. doi: 10.1016/j.jcf.2018.08.007. Epub 2018 Sep 7.

PMID:
30201329
6.

Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis.

Schechter MS, Michel S, Liu S, Seo BW, Kapoor M, Khurmi R, Haupt M.

J Pediatr Gastroenterol Nutr. 2018 Oct;67(4):520-526. doi: 10.1097/MPG.0000000000002108.

7.

Impact of a program ensuring consistent response to acute drops in lung function in children with cystic fibrosis.

Schechter MS, Schmidt HJ, Williams R, Norton R, Taylor D, Molzhon A.

J Cyst Fibros. 2018 Nov;17(6):769-778. doi: 10.1016/j.jcf.2018.06.003. Epub 2018 Jul 14.

PMID:
30017327
8.

Reevaluating approaches to cystic fibrosis pulmonary exacerbations.

Schechter MS.

Pediatr Pulmonol. 2018 Nov;53(S3):S51-S63. doi: 10.1002/ppul.24125. Epub 2018 Jul 6. Review.

PMID:
29979495
9.

Does distance to a cystic fibrosis center impact health outcomes?

Johnson B, Ngueyep R, Schechter MS, Serban N, Swann J.

Pediatr Pulmonol. 2018 Mar;53(3):284-292. doi: 10.1002/ppul.23940. Epub 2018 Jan 23.

PMID:
29359447
10.

Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States.

Sawicki GS, Ostrenga J, Petren K, Fink AK, D'Agostino E, Strassle C, Schechter MS, Rosenfeld M.

Ann Am Thorac Soc. 2018 Feb;15(2):234-240. doi: 10.1513/AnnalsATS.201705-357OC.

PMID:
29220199
11.

Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary Exacerbations.

Schechter MS, VanDevanter DR, Pasta DJ, Short SA, Morgan WJ, Konstan MW; Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Ann Am Thorac Soc. 2018 Feb;15(2):225-233. doi: 10.1513/AnnalsATS.201702-111OC.

PMID:
29140726
12.

Variation in surgical management of neurogenic bowel among centers participating in National Spina Bifida Patient Registry.

Routh JC, Joseph DB, Liu T, Schechter MS, Thibadeau JK, Chad Wallis M, Ward EA, Wiener JS.

J Pediatr Rehabil Med. 2017 Dec 11;10(3-4):303-312. doi: 10.3233/PRM-170460.

13.

Is It Acceptable to Assess Prenatal Smoking Risk to Infants without Considering Socioeconomic Status?

Ong T, Schechter MS.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):965-966. doi: 10.1164/rccm.201708-1750LE. No abstract available.

14.

Bladder Reconstruction Rates Differ among Centers Participating in National Spina Bifida Patient Registry.

Routh JC, Joseph DB, Liu T, Schechter MS, Thibadeau JK, Wallis MC, Ward EA, Wiener JS.

J Urol. 2018 Jan;199(1):268-273. doi: 10.1016/j.juro.2017.08.084. Epub 2017 Aug 19.

15.

Comparing effectiveness and outcomes in asthma and cystic fibrosis.

Schechter MS.

Paediatr Respir Rev. 2017 Sep;24:24-28. doi: 10.1016/j.prrv.2017.06.002. Epub 2017 Jun 12. Review.

PMID:
28712576
16.

Risk factors for mortality before age 18 years in cystic fibrosis.

McColley SA, Schechter MS, Morgan WJ, Pasta DJ, Craib ML, Konstan MW.

Pediatr Pulmonol. 2017 Jul;52(7):909-915. doi: 10.1002/ppul.23715. Epub 2017 Apr 24.

PMID:
28436621
17.

Reducing practice variation through clinical pathways-Is it enough?

Ren CL, Schechter MS.

Pediatr Pulmonol. 2017 May;52(5):577-579. doi: 10.1002/ppul.23653. Epub 2017 Jan 30. No abstract available.

PMID:
28135046
18.

Frequency and costs of pulmonary exacerbations in patients with cystic fibrosis in the United States.

Rubin JL, Thayer S, Watkins A, Wagener JS, Hodgkins PS, Schechter MS.

Curr Med Res Opin. 2017 Apr;33(4):667-674. doi: 10.1080/03007995.2016.1277196. Epub 2017 Feb 9.

PMID:
28058864
19.

Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina Bifida.

Routh JC, Cheng EY, Austin JC, Baum MA, Gargollo PC, Grady RW, Herron AR, Kim SS, King SJ, Koh CJ, Paramsothy P, Raman L, Schechter MS, Smith KA, Tanaka ST, Thibadeau JK, Walker WO, Wallis MC, Wiener JS, Joseph DB.

J Urol. 2016 Dec;196(6):1728-1734. doi: 10.1016/j.juro.2016.07.081. Epub 2016 Jul 27.

20.

Socioeconomic status and health outcomes: cystic fibrosis as a model.

Oates GR, Schechter MS.

Expert Rev Respir Med. 2016 Sep;10(9):967-77. doi: 10.1080/17476348.2016.1196140. Epub 2016 Jun 9. Review.

PMID:
27268142
21.

Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.

Sanders DB, Fink A, Mayer-Hamblett N, Schechter MS, Sawicki GS, Rosenfeld M, Flume PA, Morgan WJ.

J Pediatr. 2015 Nov;167(5):1081-8.e1. doi: 10.1016/j.jpeds.2015.07.044. Epub 2015 Sep 2.

22.

Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis.

Heltshe SL, Saiman L, Popowitch EB, Miller MB, Kloster M, Thompson V, Ferkol TW, Hoover WC, Schechter MS, Muhlebach MS.

J Pediatric Infect Dis Soc. 2015 Sep;4(3):225-31. doi: 10.1093/jpids/piu048. Epub 2014 Jun 9.

23.

Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.

Sanders DB, Emerson J, Ren CL, Schechter MS, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group.

Ann Am Thorac Soc. 2015 Aug;12(8):1170-6. doi: 10.1513/AnnalsATS.201504-198OC.

24.

Rate of Uptake of Ivacaftor Use after U.S. Food and Drug Administration Approval among Patients Enrolled in the U.S. Cystic Fibrosis Foundation Patient Registry.

Sawicki GS, Dasenbrook E, Fink AK, Schechter MS.

Ann Am Thorac Soc. 2015 Aug;12(8):1146-52. doi: 10.1513/AnnalsATS.201504-214OC.

PMID:
26073026
25.

Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.

Cogen J, Emerson J, Sanders DB, Ren C, Schechter MS, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group.

Pediatr Pulmonol. 2015 Aug;50(8):763-70. doi: 10.1002/ppul.23217. Epub 2015 Jun 9.

26.

Inhaled aztreonam lysine versus inhaled tobramycin in cystic fibrosis. An economic evaluation.

Schechter MS, Trueman D, Farquharson R, Higuchi K, Daines CL.

Ann Am Thorac Soc. 2015 Jul;12(7):1030-8. doi: 10.1513/AnnalsATS.201312-453OC.

PMID:
26053185
27.

Official American Thoracic Society technical standards: flexible airway endoscopy in children.

Faro A, Wood RE, Schechter MS, Leong AB, Wittkugel E, Abode K, Chmiel JF, Daines C, Davis S, Eber E, Huddleston C, Kilbaugh T, Kurland G, Midulla F, Molter D, Montgomery GS, Retsch-Bogart G, Rutter MJ, Visner G, Walczak SA, Ferkol TW, Michelson PH; American Thoracic Society Ad Hoc Committee on Flexible Airway Endoscopy in Children.

Am J Respir Crit Care Med. 2015 May 1;191(9):1066-80. doi: 10.1164/rccm.201503-0474ST.

PMID:
25932763
28.

Sociodemographic attributes and spina bifida outcomes.

Schechter MS, Liu T, Soe M, Swanson M, Ward E, Thibadeau J.

Pediatrics. 2015 Apr;135(4):e957-64. doi: 10.1542/peds.2014-2576. Epub 2015 Mar 16.

29.

Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.

Muhlebach MS, Heltshe SL, Popowitch EB, Miller MB, Thompson V, Kloster M, Ferkol T, Hoover WC, Schechter MS, Saiman L; STAR-CF Study Team.

Ann Am Thorac Soc. 2015 Jun;12(6):864-71. doi: 10.1513/AnnalsATS.201412-596OC.

30.

Comparing cystic fibrosis outcomes across the pond.

Taylor-Robinson DC, Schechter MS, Smyth RL.

Thorax. 2015 Mar;70(3):203-4. doi: 10.1136/thoraxjnl-2014-206393. Epub 2014 Dec 23. No abstract available.

31.

Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site.

Schechter MS, Regelmann WE, Sawicki GS, Rasouliyan L, VanDevanter DR, Rosenfeld M, Pasta D, Morgan W, Konstan MW.

Pediatr Pulmonol. 2015 May;50(5):431-40. doi: 10.1002/ppul.23147. Epub 2014 Dec 19.

PMID:
25530325
32.

Pulmonary function outcomes for assessing cystic fibrosis care.

Wagener JS, Elkin EP, Pasta DJ, Schechter MS, Konstan MW, Morgan WJ; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

J Cyst Fibros. 2015 May;14(3):376-83. doi: 10.1016/j.jcf.2014.11.008. Epub 2014 Dec 9.

33.

The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics.

Sawin KJ, Liu T, Ward E, Thibadeau J, Schechter MS, Soe MM, Walker W; NSBPR Coordinating Committee.

J Pediatr. 2015 Feb;166(2):444-50.e1. doi: 10.1016/j.jpeds.2014.09.039. Epub 2014 Oct 30.

34.

ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma.

Belani R, Oliveira G, Erikson GA, Ra S, Schechter MS, Lee JK, Shipman WJ, Haaser SM, Torkamani A.

Oncogenesis. 2014 Jul 7;3:e111. doi: 10.1038/oncsis.2014.25.

35.

Risk factors for quantity not sufficient sweat collection in infants 3 months or younger.

Collins MN, Brawley CB, McCracken CE, Shankar PR, Schechter MS, Rogers BB.

Am J Clin Pathol. 2014 Jul;142(1):72-5. doi: 10.1309/AJCPLHG2BUVBT5LY.

PMID:
24926088
36.

Pulmonary embolism without deep venous thrombosis: De novo or missed deep venous thrombosis?

Van Gent JM, Zander AL, Olson EJ, Shackford SR, Dunne CE, Sise CB, Badiee J, Schechter MS, Sise MJ.

J Trauma Acute Care Surg. 2014 May;76(5):1270-4. doi: 10.1097/TA.0000000000000233.

PMID:
24747459
37.

Improving inpatient cystic fibrosis pulmonary exacerbation care: two success stories.

Antos NJ, Quintero DR, Walsh-Kelly CM, Noe JE, Schechter MS.

BMJ Qual Saf. 2014 Apr;23 Suppl 1:i33-i41. doi: 10.1136/bmjqs-2013-002367.

PMID:
24608549
38.

Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project.

Boyle MP, Sabadosa KA, Quinton HB, Marshall BC, Schechter MS.

BMJ Qual Saf. 2014 Apr;23 Suppl 1:i15-i22. doi: 10.1136/bmjqs-2013-002369. Review.

PMID:
24608546
39.

Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis.

Haupt ME, Kwasny MJ, Schechter MS, McColley SA.

J Pediatr. 2014 May;164(5):1110-1115.e1. doi: 10.1016/j.jpeds.2014.01.022. Epub 2014 Feb 20.

PMID:
24560182
40.

The impact of preinjury anticoagulants and prescription antiplatelet agents on outcomes in older patients with traumatic brain injury.

Peck KA, Calvo RY, Schechter MS, Sise CB, Kahl JE, Shackford MC, Shackford SR, Sise MJ, Blaskiewicz DJ.

J Trauma Acute Care Surg. 2014 Feb;76(2):431-6. doi: 10.1097/TA.0000000000000107.

PMID:
24458049
41.

The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement.

Schechter MS, Fink AK, Homa K, Goss CH.

BMJ Qual Saf. 2014 Apr;23 Suppl 1:i9-14. doi: 10.1136/bmjqs-2013-002378. Epub 2014 Jan 17. Review. No abstract available.

PMID:
24443584
42.

Wealth as a disease modifier in cystic fibrosis.

Schechter MS.

Lancet Respir Med. 2013 Apr;1(2):93-5. doi: 10.1016/S2213-2600(13)70014-6. Epub 2013 Feb 1. No abstract available.

PMID:
24429076
43.

Long-term effects of pregnancy and motherhood on disease outcomes of women with cystic fibrosis.

Schechter MS, Quittner AL, Konstan MW, Millar SJ, Pasta DJ, McMullen A; Scientific Advisory Group; Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis.

Ann Am Thorac Soc. 2013 Jun;10(3):213-9. doi: 10.1513/AnnalsATS.201211-108OC.

PMID:
23802817
44.

Back to the future: reducing reliance on torso computed tomography in the initial evaluation of blunt trauma.

Sise MJ, Kahl JE, Calvo RY, Sise CB, Morgan JA, Shackford SR, Shackford MC, Bandle J, Peck KA, Schechter MS.

J Trauma Acute Care Surg. 2013 Jan;74(1):92-7; discussion 97-9. doi: 10.1097/TA.0b013e3182788f6f.

PMID:
23271082
45.

Testing the feasibility of a National Spina Bifida Patient Registry.

Thibadeau JK, Ward EA, Soe MM, Liu T, Swanson M, Sawin KJ, Freeman KA, Castillo H, Rauen K, Schechter MS.

Birth Defects Res A Clin Mol Teratol. 2013 Jan;97(1):36-41. doi: 10.1002/bdra.23094. Epub 2012 Nov 2.

46.

Benchmarking to improve the quality of cystic fibrosis care.

Schechter MS.

Curr Opin Pulm Med. 2012 Nov;18(6):596-601. doi: 10.1097/MCP.0b013e328358d533. Review.

PMID:
22965277
47.

Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.

Regelmann WE, Schechter MS, Wagener JS, Morgan WJ, Pasta DJ, Elkin EP, Konstan MW; Investigators of the Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2013 Jul;48(7):649-57. doi: 10.1002/ppul.22658. Epub 2012 Sep 4.

48.

Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial.

Grossmann RE, Zughaier SM, Kumari M, Seydafkan S, Lyles RH, Liu S, Sueblinvong V, Schechter MS, Stecenko AA, Ziegler TR, Tangpricha V.

Dermatoendocrinol. 2012 Apr 1;4(2):191-7. doi: 10.4161/derm.20332.

49.

Diagnosis and management of childhood obstructive sleep apnea syndrome.

Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, Schechter MS, Ward SD, Sheldon SH, Shiffman RN, Lehmann C, Spruyt K; American Academy of Pediatrics.

Pediatrics. 2012 Sep;130(3):e714-55. doi: 10.1542/peds.2012-1672. Epub 2012 Aug 27. Review.

PMID:
22926176
50.

Diagnosis and management of childhood obstructive sleep apnea syndrome.

Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, Schechter MS, Sheldon SH, Spruyt K, Ward SD, Lehmann C, Shiffman RN; American Academy of Pediatrics.

Pediatrics. 2012 Sep;130(3):576-84. doi: 10.1542/peds.2012-1671. Epub 2012 Aug 27.

PMID:
22926173

Supplemental Content

Loading ...
Support Center